Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 631 AL 645

Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M(1) positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants

Conley AC, Key AP, Blackford JU, Russell JK, Albert KM, Gong X, Bubser M, Rook JM, Conn PJ, Lindsley CW, Jones CK, Newhouse PA.

Alzheimers Res Ther. 2025 Jul 1;17(1):144. doi: 10.1186/s13195-025-01798-4.

Translational computerized clinical decision support systems for Alzheimer's disease: A systematic review

Lu P, Chen M, Chen L, Lin F, Yang H, Wang Y, Ding X.

J Alzheimers Dis. 2025 Jul;106(2):443-483. doi: 10.1177/13872877251343241. Epub 2025 Jul 1.

Multicomponent exercise interventions for older adults with Alzheimer's disease: A systematic review and meta-analytical perspective

Yang D, Hou N, Jia M.

J Alzheimers Dis. 2025 Aug;106(3):876-889. doi: 10.1177/13872877251346989. Epub 2025 Jun 2.

Effect of antidiabetic drugs in Alzheimer´s disease: a systematic review of preclinical and clinical studies

Corraliza-Gomez M, Vargas-Soria M, Garcia-Alloza M.

Mol Neurodegener. 2025 Oct 27;20(1):112. doi: 10.1186/s13024-025-00894-1.

Effect of the probiotic Escherichia coli Nissle 1917 on serum levels of NADPH oxidase-2 and lipopolysaccharide in patients with Alzheimer's disease

Loffredo L, Alfano AR, Ettorre E, Desideri G, Carnevale R, Forte M, Maglione V, Bartimoccia S, Castellani V, Totè CM, Pignatelli P, Violi F; Neurodegenerative Disease study group.

J Alzheimers Dis. 2025 Jul;106(2):774-782. doi: 10.1177/13872877251345157. Epub 2025 Jul 1.

Efficacy and Safety of Bilateral Deep Brain Stimulation (DBS) for Severe Alzheimer's Disease: A Comparative Analysis of Fornix Versus Basal Ganglia of Meynert

Xu J, Liu B, Shang G, Feng Z, Yang H, Chen Y, Yu X, Mao Z.

CNS Neurosci Ther. 2025 Apr;31(4):e70285. doi: 10.1111/cns.70285.

Patient-Related Barriers to Digital Technology Adoption in Alzheimer Disease: Systematic Review

Panzavolta A, Arighi A, Guido E, Lavorgna L, Di Lorenzo F, Dodich A, Cerami C.

JMIR Aging. 2025 Apr 10;8:e64324. doi: 10.2196/64324.

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study

Sol O, Mermoud J, Hallikainen M, Kurl S, Rinne J, Dautzenberg P, Vijverberg EGB, Mummery C, Börjesson-Hanson A, Jonsson M, Ritchie C, Pennington C, Vukicevic M, Gollwitzer E, Fiorini E, Hickman DT, Hliva V, Gray J, Gerasymchuk V, Wagg J, Fournier N, Lê B, Kezic I, Steukers L, Triana-Baltzer G, Theunis C, Streffer J, Kosco-Vilbois M, Pfeifer A, Scheltens P.

EBioMedicine. 2025 Oct;120:105940. doi: 10.1016/j.ebiom.2025.105940. Epub 2025 Sep 18.

Strain specific effects of probiotic supplementation on serum amino acid profiles in Alzheimer's disease: a randomized, double blind, placebo controlled trial

Jouni N, Akhgarjand C, Vahabi Z, Shab-Bidar S, Khalifeh H, Djafarian K.

Sci Rep. 2025 Aug 15;15(1):29924. doi: 10.1038/s41598-025-15355-4.

Rapid health technology assessment of galantamine for the treatment of Alzheimer's disease: A review

Xing B, Yang J, Hua H, Jiang R.

Medicine (Baltimore). 2025 Jun 6;104(23):e42744. doi: 10.1097/MD.0000000000042744.

Gray matter and white matter functional connectivity changes induced by rTMS concurrent with cognitive training in Alzheimer's disease

Fang J, Shi Y, Ba L, Zhang M, Li M, Zheng N, Qin Y, Zhu W.

Brain Res Bull. 2025 Aug;228:111418. doi: 10.1016/j.brainresbull.2025.111418. Epub 2025 Jun 3.

Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer's disease under intravenous trehalose treatment

Radbakhsh S, Abrego-Guandique DM, Bacchetti T, Aghaee-Bakhtiari SH, Mahmoudi A, Manteghi AA, Bazyari MJ, Cione E, Ferretti G, Sahebkar A.

Brain Res. 2025 Jun 15;1857:149607. doi: 10.1016/j.brainres.2025.149607. Epub 2025 Apr 3.

A review of the TGF-β1 pathway in Alzheimer's disease and depression: Possible restoration potential of antidepressants

Eleni I, Theofanis V, Zisis B, Eleni S.

Neuroscience. 2025 Oct 15;585:429-440. doi: 10.1016/j.neuroscience.2025.09.010. Epub 2025 Sep 12.

Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)

Sankhe K, Tumati S, Perin J, Rivet L, Vieira D, Rosenberg PB, Herrmann N, Shade D, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey AI, Mintzer J, Lanctôt KL.

Int Psychogeriatr. 2025 Mar;37(2):100012. doi: 10.1016/j.inpsyc.2024.100012. Epub 2024 Dec 4.

Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease

Budda B, Mitra A, Park L, Long H, Kurnellas M, Bien-Ly N, Estacio W, Burgess B, Chao G, Schwabe T, Paul R, Kenkare-Mitra S, Rosenthal A.

Alzheimers Res Ther. 2025 Jul 25;17(1):174. doi: 10.1186/s13195-025-01817-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias